Exane Derivatives’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $87.3K | Buy |
2,279
+2,249
| +7,497% | +$86.1K | 0.05% | 273 |
|
|
2022
Q1 | $1.24K | Hold |
30
| – | – | ﹤0.01% | 788 |
|
|
2021
Q4 | $1.13K | Hold |
30
| – | – | ﹤0.01% | 682 |
|
|
2021
Q3 | $989 | Sell |
30
-4,417
| -99% | -$146K | ﹤0.01% | 846 |
|
|
2021
Q2 | $282K | Hold |
4,447
| – | – | 0.06% | 294 |
|
|
2021
Q1 | $252K | Buy |
4,447
+189
| +4% | +$10.7K | 0.07% | 257 |
|
|
2020
Q4 | $347K | Buy |
4,258
+3,015
| +243% | +$246K | 0.1% | 223 |
|
|
2020
Q3 | $88.6K | Sell |
1,243
-57
| -4% | -$4.06K | 0.03% | 296 |
|
|
2020
Q2 | $107K | Hold |
1,300
| – | – | 0.03% | 265 |
|
|
2020
Q1 | $76.5K | Buy |
+1,300
| New | +$76.5K | 0.02% | 297 |
|